Perspective Therapeutics, Inc. — Director's Dealing 2017

Jan 26, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-01-17

Reporting Person: Branson Matthew (Principal Fin & Acct Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$1.53	2025-03-10	Common Stock (15000)		Direct
Stock Option	$0.93	2026-06-21	Common Stock (25000)		Direct

Footnotes

F1: 5,000 are exercisable as of the date of this Form 3, 5,000 will become exercisable on March 10, 2017, and 5,000 will become exercisable on March 10, 2018.

F2: 5,000 will become exercisable on June 21, 2017, 5,000 will become exercisable on June 21, 2018, 5,000 will become exercisable on June 21, 2019, 5,000 will become exercisable on June 21, 2020, and 5,000 will become exercisable on June 21, 2021.